הבדלים בין גרסאות בדף "קפטופריל - Captopril"
מתוך ויקירפואה
שורה 6: | שורה 6: | ||
|מאגר משרד הבריאות=[http://www.health.gov.il/units/pharmacy/trufot/Mucar_List.asp?p=1&Sr_Type=Activ&Y_Name=CAPTOPRIL&Letter=CAPTOPRIL&safa= "קפטופריל"] | |מאגר משרד הבריאות=[http://www.health.gov.il/units/pharmacy/trufot/Mucar_List.asp?p=1&Sr_Type=Activ&Y_Name=CAPTOPRIL&Letter=CAPTOPRIL&safa= "קפטופריל"] | ||
|סל הבריאות=כלול. | |סל הבריאות=כלול. | ||
− | |הגבלות=תרופה שאושרה לשימוש כללי בקופ | + | |הגבלות=תרופה שאושרה לשימוש כללי בקופ"ח. |
|התוויות= Hypertension, Congestive Heart Failure, insulin dependent diabetic nephropathey in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl. Left ventricular dysfunction after myocardial infarction. Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction < or equals to 40 % and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients. | |התוויות= Hypertension, Congestive Heart Failure, insulin dependent diabetic nephropathey in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl. Left ventricular dysfunction after myocardial infarction. Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction < or equals to 40 % and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients. | ||
גרסה מ־19:10, 2 באפריל 2011
קפטופריל - Captopril | ||
---|---|---|
שמות מסחריים | קפטופריל (Captopril)® אסריל (Aceril)® | |
![]() | ||
קפטופריל | ||
קבוצה פרמקולוגית (ATC) | "ACE INHIBITORS, PLAIN" | |
סל הבריאות | כלול. | |
התוויות |
Hypertension, Congestive Heart Failure, insulin dependent diabetic nephropathey in hypertensive and non hypertensive patients in cases where the serum creatinine level < 2.5 mg/dl. Left ventricular dysfunction after myocardial infarction. Captopril is indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction < or equals to 40 % and to reduce the incidence of overt heart failure and subsequent hospitalization for congestive heart failure in these patients.
| |
יוצר הערך | מערכת ויקי רפואה | |